Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review

被引：0

作者：

Vincent Dochez

Hélène Caillon

Edouard Vaucel

Jérôme Dimet

Norbert Winer

Guillaume Ducarme

机构：

[1] CHU de Nantes,Service de Gynécologie

[2] CHU de Nantes,Obstétrique

[3] Centre Hospitalier Départemental Vendée,Service de Biochimie

[4] Centre Hospitalier Départemental Vendée,Centre de recherche clinique

来源：

Journal of Ovarian Research | / 12卷

关键词：

HE4; CA125; ROMA; RMI; Ovarian cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an update on the biological markers for diagnosing ovarian cancer, specifically HE4, CA 125, RMI and ROMA algorithms.

引用

共 50 条

[21] Diagnostic value of HE4, CA125 and the ROMA index in ovarian cancer patients from a tertiary center
Hogdall, E.
Karlesn, M. A.
Christensen, I. J.
Lundvall, L.
Engelholm, S. A.
Nedergaard, L.
Pedersen, Tonnes A.
Hartwell, D.
Hogdall, C. K.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 : S42 - S42
[22] Measuring HE4 alongside CA125 for ovarian cancer diagnosis: A pilot clinical study
Crawford, S. Michael
Evans, Colin
Shaw, Alison
Barr, Chloe E.
Crosbie, Emma J.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 (12) : 1725 - 1726
[23] The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
Zheng, Li-e
Qu, Jun-ying
He, Fei
OPEN MEDICINE, 2016, 11 (01): : 125 - 132
[24] Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
Terlikowska, Katarzyna M.
Dobrzycka, Bozena
Witkowska, Anna M.
Mackowiak-Matejczyk, Beata
Sledziewski, Tomasz Kamil
Kinalski, Maciej
Terlikowski, Slawomir J.
JOURNAL OF OVARIAN RESEARCH, 2016, 9
[25] Preoperative HE4, CA125 and ROMA in the differential diagnosis of benign and malignant adnexal masses
Katarzyna M. Terlikowska
Bozena Dobrzycka
Anna M. Witkowska
Beata Mackowiak-Matejczyk
Tomasz Kamil Sledziewski
Maciej Kinalski
Slawomir J. Terlikowski
Journal of Ovarian Research, 9
[26] Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass
Karlsen, Mona Aarenstrup
Sandhu, Noreen
Hogdall, Claus
Christensen, Ib Janie
Nedergaard, Lotte
Lundvall, Lene
Engelholm, Svend A.
Pedersen, Anette T.
Hartwell, Dorthe
Lydolph, Magnus
Laursen, Inga Alice
Hegdall, Estrid V. S.
GYNECOLOGIC ONCOLOGY, 2012, 127 (02) : 379 - 383
[27] Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer
Granato, Teresa
Midulla, Cecilia
Longo, Flavia
Colaprisca, Barbara
Frati, Luigi
Anastasi, Emanuela
TUMOR BIOLOGY, 2012, 33 (05) : 1335 - 1339
[28] Clinical Utility and Diagnostic Accuracy of ROMA, RMI, ADNEX, HE4, and CA125 in the Prediction of Malignancy in Adnexal Masses
Spagnol, Giulia
Marchetti, Matteo
Carollo, Massimo
Bigardi, Sofia
Tripepi, Marta
Facchetti, Emma
De Tommasi, Orazio
Vitagliano, Amerigo
Cavallin, Francesco
Tozzi, Roberto
Saccardi, Carlo
Noventa, Marco
CANCERS, 2024, 16 (22)
[29] DISEASE RELAPSE IN OVARIAN CANCER PATIENTS DETECTED BY HE4 AND CA125
Steffensen, K.
Waldstrom, M.
Brandslund, I.
Lund, B.
Sorensen, S. M.
Petzold, M.
Jakobsen, A.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 187 - 188
[30] Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer
Andersen, M. Robyn
Goff, Barbara A.
Lowe, Kimberly A.
Scholler, Nathalie
Bergan, Lindsay
Drescher, Charles W.
Paley, Pamela
Urban, Nicole
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 378 - 383

← 1 2 3 4 5 →